FDAsafety guidance66% confidence
FDA AP — VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER (SUPPL)
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Saptalis Pharmaceuticals; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Application NDA050671. Sponsor: BAXTER HLTHCARE. Submission status: AP. Submission type: SUPPL. Review priority: STANDARD. Active ingredients: VANCOMYCIN HYDROCHLORIDE.
Supporting Context
- Therapeutic area
- Neurology · Antihistamine
- Sub-indication
- General
Related signal: FDA Approves Hydroxyzine Hydrochloride ANDA220271 by Saptalis Pharmaceuticals